Bedbugs are near the
top of the list of things The Dismal Political Economist, and presumably
others, do not want to consider. The
insects get their name because they hid in the bedroom and when the victim is
sleeping they come out and bite them.
All in all not the experience one wants to have in the bedroom.
But it turns out that
researchers may
have found a cure to the problem, although for some the cure may be as bad
as the disease.
Gimme Your Best Shot |
You take the pill and go to
bed — perchance even to sleep, if you can sleep knowing how patiently bedbugs
wait in your walls or mattress, sniffing for the sweet stream of your exhaled
carbon dioxide and for your warm skin to grow still. You let them bite you. And
then — in a few days — they die.
The specific pill is something that was developed for other
uses, notably diseases in tropical countries and for treating or preventing
heartworm infestation in dogs.
And it’s not as if the drug
is rare and dangerous. It’s already in thousands of American households:
ivermectin, the active ingredient in the beef-flavored Heartgard Chewables that
kill heartworm in dogs.
Still the research in its early stages,
Dr. Sheele is not advising
bedbug-tormented Americans to start eating Fido’s worm tablets. With only four
volunteers, his study was tiny and preliminary, he emphasized. Neither the Food
and Drug Administration nor any medical society has approved using ivermectin
this way, and no one yet knows what the ideal antibedbug dose is.
But one can see a whole new employment opportunity opening
up. Mitt Romney and the folks that
deplore the so-called 47% of Americans they see as living off the work and
sweat of the rest of the country may well propose that as a condition to
receiving federal help in the form of unemployment insurance, Medicare, Social
Security etc (those are the major parts of the 47%) the individuals move into
an infested bedroom, take the medicine and let the bedbugs bit them to kill the bedbugs. Such a policy would fit with their philosophy
of governing.
No comments:
Post a Comment